iECURE Presents Updated Clinical Data from OTC-HOPE Trial of ECUR-506 in Neonatal-Onset Ornithine Transcarbamylase Deficiency at SSIEM 2026
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| (NASDAQ: DTIL) | Delayed: 6.78 +0.07 (1.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.71 | 52 Week High | $ | |||
| Open | $6.70 | 52 Week Low | $ | |||
| Day High | $6.93 | P/E | N/A | |||
| Day Low | $6.58 | EPS | $ | |||
| Volume | 132,429 | |||||
